Chicago Partners Investment Group’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,310
Closed -$56.5K 683
2022
Q4
$56.5K Buy
+14,310
New +$56.5K ﹤0.01% 628